EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Revisiting epigenetic regulation in cancer: Evolving trends and translational implications

Mohammad Afsar Khan, Dhruv Mishra, Ranjan Kumar, Hifzur R Siddique

International Review of Cell and Molecular Biology · 2025

DOI: 10.1016/bs.ircmb.2024.09.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Review of Cell and Molecular Biology, 2025. Verfasst von Mohammad Afsar Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Cancer Genetics & Translational Research Lab, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh, India. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Neoplasms, Translational Research, Biomedical. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 112 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a leading cause of mortality worldwide. The evolving role of epigenetics and tumor microenvironments of cancer pose significant challenges to the management of cancer. Besides genetics, epigenetic changes play a crucial role in the alteration of cellular machinery, progression, metastasis, epithelial-mesenchymal transition, and chemoresistance. Epigenetic changes such as DNA and RNA methylation, histone modifications, and chromatin modeling directly or indirectly influence the different stages of cancer from initiation to chemoresistant phenotype. In addition, alterations in the epigenetic machinery, such as hypo- or hyperactivation of proteins involved in epigenetic modifications, can lead to different health complications, including cancer. Recently, epi-drugs or epigenetic drugs offer emerging hope for the treatment and management of this deadly disease. Various epigenetic drugs targeting factors responsible for epigenetic modifications in cancer are currently under clinical trials. This chapter provides an overview of epigenetic modifications, their clinical implications, and the potential of epigenetic drugs for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticNeoplasmsTranslational Research, BiomedicalHumansAnimalsDNA Methylation

Stichwörter der Autor:innen

CancerChemotherapyEpidrugEpigeneticsTumor Microenvironment

Autor:innen und Institutionen

  • Molecular Cancer Genetics & Translational Research Lab, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh, India.
  • Department of Zoology, DAV College (PG), Maa Shakumbhari University, Muzaffarnagar, India.
  • School of Life Science, Jawaharlal Nehru University (JNU), New Delhi, India.
  • Molecular Cancer Genetics & Translational Research Lab, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh, India. Electronic address: hifzur.zo@amu.ac.in.

Zitieren

APA

Khan, M. A., Mishra, D., Kumar, R., & Siddique, H. R. (2025). Revisiting epigenetic regulation in cancer: Evolving trends and translational implications. International Review of Cell and Molecular Biology. https://doi.org/10.1016/bs.ircmb.2024.09.002

Vancouver

Khan MA, Mishra D, Kumar R, Siddique HR. Revisiting epigenetic regulation in cancer: Evolving trends and translational implications. International Review of Cell and Molecular Biology. 2025. doi:10.1016/bs.ircmb.2024.09.002

BibTeX
@article{Khan2025,
  author = {Khan, Mohammad Afsar and Mishra, Dhruv and Kumar, Ranjan and Siddique, Hifzur R},
  title = {Revisiting epigenetic regulation in cancer: Evolving trends and translational implications},
  journal = {International Review of Cell and Molecular Biology},
  year = {2025},
  doi = {10.1016/bs.ircmb.2024.09.002}
}
Kostenlos starten →